Effect of osteoporosis in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27.
Lois E. Shepherd
No relevant relationships to disclose
Judy-Anne W. Chapman
No relevant relationships to disclose
Suhail M. Ali
No relevant relationships to disclose
Liting Zhu
No relevant relationships to disclose
Kim Leitzel
Research Funding - AstraZeneca; Pfizer
Paul Edward Goss
Honoraria - Novartis; Pfizer
Allan Lipton
Research Funding - AstraZeneca; Pfizer